Cabiralizumab April 13, 2017 Cabiralizumab Trade Name Orphan Indication Tenosynovial giant cell tumour, localised and diffuse type EU Market Approval EU EU Designation Date 2016-12-12 00:00:00 Sponsor TMC Pharma Services Ltd
